Dongsung Pharm (002210) — Cash Flow Reinvestment Rate
Dongsung Pharm (002210) has a Cash Flow Reinvestment Rate of 0.25x as of June 2025, reinvesting ₩1.07 Billion (capex ₩0.00 plus investments ₩-1.07 Billion) from operating cash flow of ₩4.20 Billion. Check Dongsung Pharm earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Dongsung Pharm Cash Flow Reinvestment Rate (2010–2020)
Historical reinvestment intensity for Dongsung Pharm across 4 annual periods. Explore 002210 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Dongsung Pharm (2010–2020)
Year-by-year capital reinvestment analysis for Dongsung Pharm. For live market cap and broader valuation context, see 002210 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 2.51x | ₩12.56 Billion | ₩5.01 Billion | ₩6.92 Billion | ▼ -83.5% |
| 2018 | 15.21x | ₩21.19 Billion | ₩1.39 Billion | ₩2.13 Billion | ▲ +668.2% |
| 2017 | 1.98x | ₩3.56 Billion | ₩1.80 Billion | ₩3.00 Billion | ▲ +588.0% |
| 2010 | 0.29x | ₩1.06 Billion | ₩3.68 Billion | ₩847.33 Million | — |